CLINICAL_TRIALS
withdrawal
· 2024-02-28
Clinical Trial Update: Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil [Phase 3]
Summary
Phase 3 trial of fixed-dose combination etoricoxib + cyclobenzaprine for pain relief after third molar extraction was withdrawn in Brazil.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eurofarma Laboratorios S.A. | Conditions: Third Molar Extraction | Phase 3 | Status: WITHDRAWN